Liu Feng, Huang Zhuang-Zhuang, Sun Yu-Hong, Li Ting, Yang Dong-Hua, Xu Gang, Su Ying-Ying, Zhang Tao
School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, 710061, PR China.
Shaanxi Buchang Pharmaceutical Co. Ltd, Xi'an, Shaanxi, 710075, PR China.
Phytother Res. 2017 Mar;31(3):507-515. doi: 10.1002/ptr.5787. Epub 2017 Feb 6.
Guanxin Shutong capsule is a traditional Chinese medicine for the treatment of myocardial ischemia (MI). Previous studies have shown that the formula has four main active ingredients (FMAI), protocatechuic acid, cryptotanshinone, borneol, and eugenol. However, the mechanisms of action of these FMAI against MI injury are still not well known. The aim of the present study was to evaluate the protective effects of the FMAI on MI in vitro and in vivo. In vitro, rat neonatal cardiomyocytes were isolated, the cell viability and apoptosis rate were, respectively, measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method and fluorescence activating cell sorter, and the intracellular calcium concentration ([Ca ] ) and CaM and CaMKII δ mRNA as well as protein levels were determined. Meanwhile, their downstream targets of RyR2 and PLB were also measured by western blot. In vivo, a rat model of coronary artery ligation was used to evaluate the cardioprotective effects. Infarct sizes of heart tissues and levels of serum biochemical indicators, including creatine kinase, lactate dehydrogenase, superoxide dismutase, and glutamate oxaloacetic transaminase, were measured. The in vitro results showed that the FMAI inhibited cell apoptosis, reduced [Ca ] , decreased the expression of CaM and CaMKII δ, and increased the expression of RyR2 and PLB. In vivo, the FMAI diminished infract size, reduced creatine kinase, lactate dehydrogenase, and aspartate aminotransferase levels, and enhanced superoxide dismutase activity. In conclusion, our data suggest that the FMAI suppressed calcium overload and exerted its protective effect via its antioxidant, antiinflammatory, and anti-apoptosis activities. Copyright © 2017 John Wiley & Sons, Ltd.
冠心舒通胶囊是一种用于治疗心肌缺血的中药。先前的研究表明,该方剂有四种主要活性成分,即原儿茶酸、隐丹参酮、冰片和丁香酚。然而,这些主要活性成分抗心肌缺血损伤的作用机制仍不清楚。本研究的目的是评估这些主要活性成分在体外和体内对心肌缺血的保护作用。体外实验中,分离大鼠新生心肌细胞,分别采用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(MTT)法和荧光激活细胞分选仪测定细胞活力和凋亡率,并测定细胞内钙浓度([Ca])、钙调蛋白(CaM)和钙/钙调蛋白依赖性蛋白激酶Ⅱδ(CaMKⅡδ)的mRNA及蛋白水平。同时,还通过蛋白质免疫印迹法检测其下游靶点兰尼碱受体2(RyR2)和受磷蛋白(PLB)。体内实验采用冠状动脉结扎大鼠模型评估心脏保护作用。测定心脏组织梗死面积及血清生化指标水平,包括肌酸激酶、乳酸脱氢酶、超氧化物歧化酶和谷氨酸草酰乙酸转氨酶。体外实验结果显示,这些主要活性成分抑制细胞凋亡,降低[Ca],减少CaM和CaMKⅡδ的表达,并增加RyR2和PLB的表达。体内实验中,这些主要活性成分减小梗死面积,降低肌酸激酶、乳酸脱氢酶和天冬氨酸转氨酶水平,并增强超氧化物歧化酶活性。总之,我们的数据表明,这些主要活性成分通过其抗氧化、抗炎和抗凋亡活性抑制钙超载并发挥保护作用。版权所有©2017约翰威立父子有限公司。